In this webinar...
Parexel is at the forefront of change. We make studies more accessible by deploying our virtual trials service to reduce the practical, financial and geographical barriers to participation, thereby achieving better recruitment and retention.
- Why are Decentralized Clinical Trials (DCT) important?
- Why Parexel’s Decentralized Clinical Trials are different?
- How we are driving innovation through partnering?
- Sanjay Vyas, SVP and Managing Director, Parexel International
- Roopa Basrur, Vice President and Country Head, Calyx India